<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Surg Res</journal-id><journal-id journal-id-type="iso-abbrev">J. Surg. Res.</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The Journal of surgical research</journal-title></journal-title-group><issn pub-type="ppub">0022-4804</issn><issn pub-type="epub">1095-8673</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6462350</article-id><article-id pub-id-type="pmcid-ver">PMC6462350.1</article-id><article-id pub-id-type="pmcaid">6462350</article-id><article-id pub-id-type="pmcaiid">6462350</article-id><article-id pub-id-type="manuscript-id">NIHMS1008290</article-id><article-id pub-id-type="pmid">30771686</article-id><article-id pub-id-type="doi">10.1016/j.jss.2019.01.038</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1008290</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1008290</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial)</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ramirez</surname><given-names initials="JL">Joel L.</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gasper</surname><given-names initials="WJ">Warren J.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khetani</surname><given-names initials="SA">Sukaynah A.</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zahner</surname><given-names initials="GJ">Greg J.</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hills</surname><given-names initials="NK">Nancy K.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mitchell</surname><given-names initials="PT">Pete T.</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sansbury</surname><given-names initials="BE">Brian E.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Conte</surname><given-names initials="MS">Michael S.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Spite</surname><given-names initials="M">Matthew</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grenon</surname><given-names initials="SM">S. Marlene</given-names></name><degrees>MD, MMSc, MBA</degrees><xref ref-type="aff" rid="A1">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label>Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Francisco, California</aff><aff id="A2"><label>b</label>Vascular Surgery Section, Veterans Affairs Medical Center, San Francisco, California</aff><aff id="A3"><label>c</label>Department of Epidemiology and Biostatistics, University of California, San Francisco, California</aff><aff id="A4"><label>d</label>Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women&#8217;s Hospital and Harvard Medical School, Building for Transformative Medicine, Boston, Massachusetts</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Authors&#8217; contributions: W.J.G., M.S.C., and S.M.G. were involved in the conception and the design of the study. J.L.R., S.A.K., P.T.M., B.E.S., and M.S. were involved in the collection of the data. All the authors were involved in the analysis and interpretation of the data. J.L.R., N.K.H., P.T.M., B.E.S., and M.S. were involved in the statistical analysis. J.L.R. wrote the initial manuscript. All the authors were involved in critically revising and editing the article. All the authors gave a final approval of the manuscript. S.M.G. maintained overall responsibility of the study and the manuscript.</p></fn><corresp id="CR1"><label>*</label><italic toggle="yes">Corresponding author</italic>. Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Francisco, 400 Parnassus Avenue, A-581, San Francisco, CA 94143. Tel.: +415 307-5275; fax: +415 750-2181. <email>marlene.grenon@ucsf.edu</email> (S.M. Grenon).</corresp><fn fn-type="COI-statement" id="FN2"><p id="P39">Disclosure</p><p id="P40">The authors have no conflicts of interest to report.</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>2</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2019</year></pub-date><volume>238</volume><issue-id pub-id-type="pmc-issue-id">332642</issue-id><fpage>164</fpage><lpage>174</lpage><pub-history><event event-type="nihms-submitted"><date><day>02</day><month>02</month><year>2019</year></date></event><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2020</year></date></event><event event-type="pmc-released-under-embargo"><date><day>15</day><month>04</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 23:25:33.200"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1008290.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">N-3 polyunsaturated fatty acid (PUFA) supplementation has been associated with reduced mortality and inflammation in patients with cardiovascular disease. There are limited data on the effects of n-3 PUFA supplementation in patients with peripheral artery disease (PAD).</p></sec><sec id="S2"><title>Materials and methods:</title><p id="P3">The OMEGA-PAD II trial was a double-blinded, randomized, placebo-controlled trial to assess the effect of 3 mo of high-dose oral n-3 PUFA supplementation on inflammation, endothelial function, and walking ability in patients with PAD.</p></sec><sec id="S3"><title>Results:</title><p id="P4">Twenty-four patients with claudication received 4.4 g/d of fish oil or placebo for 3 mo. Outcomes measured included high-sensitivity C-reactive protein levels, the omega-3 index, endothelial function as measured via flow-mediated vasodilation, walking impairment questionnaire, and a 6-min walk test. Plasma levels of specialized pro-resolving lipid mediators (SPMs) were measured by liquid-chromatography-tandem mass spectrometry. In patients treated with fish oil, the absolute mean omega-3 index significantly increased from baseline (fish oil: 7.2 &#177; 1.2%, <italic toggle="yes">P</italic> &lt; 0.001; placebo: &#8722;0.4 &#177; 0.9%, <italic toggle="yes">P</italic> = 0.31; between-group <italic toggle="yes">P</italic> &lt; 0.001). Furthermore, there were significant increases in several pathway markers of SPM biosynthesis, including several mono-hydroxyeicosapentaenoic acids and mono-hydroxydocosahexaenoic acids. We also observed significant increases in the SPM lipoxin A<sub>5</sub> (fish oil: 0.57 &#177; 0.70 pg/mL, <italic toggle="yes">P</italic> = 0.05; placebo: 0.01 &#177; 0.38 pg/mL, <italic toggle="yes">P</italic> = 0.93; between-group <italic toggle="yes">P</italic> = 0.04) and resolvin E3 (fish oil: 154 &#177; 171 pg/mL, <italic toggle="yes">P</italic> = 0.04; placebo: 32 &#177; 54 pg/mL, <italic toggle="yes">P</italic> = 0.08; between-group <italic toggle="yes">P</italic> = 0.04). There were no significant changes in high-sensitivity C-reactive protein, flow-mediated vasodilation, walking impairment questionnaire, or 6-min walk test in the fish oil group.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P5">Fish oil increases SPMs in plasma of patients with PAD. Further studies are required to determine whether these early changes translate to clinical improvements in patients with PAD.</p></sec></abstract><kwd-group><kwd>Peripheral artery disease</kwd><kwd>n-3 polyunsaturated fatty acids</kwd><kwd>Fish oils</kwd><kwd>Specialized pro-resolving lipid mediators</kwd><kwd>Other pharmacotherapy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>